Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

The Center for Medicare and Medicaid Innovation may introduce a five-year pilot model to expand access to weight loss drugs, ...

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Dr. Mehmet Oz, the Administrator of the Centers for Medicare and Medicaid Services, discussed the impending changes to the ...

Several companies, including Oracle and Microsoft, are expected to sign pledges to work on the Trump administration ...

Trump abruptly fired Bureau of Labor Statistics Commissioner Erika McEntarfer on Friday after the release of the report, ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

Dave Ramsey explains Medicare and Medicaid, highlighting differences and eligibility. Trump launches health tracking system ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.